Health Condition 1: D508- Other iron deficiency anemias
Conditions
Interventions
Intervention1: Drakshawleha: Dose : 10 gmtwice daily (with luke warm water)
Dosage form : Awaleha
Route of Administration : Oral
Time of Administration : Morning and evening before meals
Duration
Sponsors
Central Council For Research In Ayurvedic Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex aged between18 to 50 years. 2. IDA documented by hematologic indices. i. Hb 8gm-10gm. % ii. S.Ferritin iii. TIBC >450mcg/dL iv. S.Iron v. MCV vi. RDW >46fL vii. Reticulocyte count (Among these the first 3 are the essential criteria for inclusion) 3. Willing and able to participate for 112 days.
Exclusion criteria
Exclusion criteria: 1. Iron deficiency likely or definitely due to blood loss from the intestine or other sites. 2. History or evidence of intestinal malabsorption 3. Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Psycho-Neuro-Endocrinal disorders, Bleeding disorders, etc.) 4. Other causes of Anemia (sickle cell disease, thalassemia, other hemolyticAnemia, bone marrow failure, etc.) apparent by history, physical examination, and/or laboratory tests. 5. Patients on prolonged ( > 6 weeks) medication with corticosteroids, antidepressants,anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study. 6. Patients with concurrent serious hepatic disorder (defined as Aspartate AminoTransferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, AlkalinePhosphatase (ALP) > 2 times upper normal limit), or Renal Disorders (defined as S. Creatinine >1.2mg/dL), Total Serum Cholesterol & / or Serum Triglycerides > 250 mg/dl, Severe PulmonaryDysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease[COPD]). 7. Alcoholics and/or drug abusers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in peripheral blood haemoglobin concentration.Timepoint: Time Frame: Every 4 weeks (on day 0, 28th,56th,84th and 112th) | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Ferritin level, Serum Iron level, TIBC level, MCV level, Reticulocyte count, Red blood cell Count, Any adverse events.Timepoint: Time Frame: Every 4 weeks (on day 0, 28th,56th,84th and 112th) | — |
Countries
India
Contacts
Public ContactDr Vikas Nariyal
Regional Ayurveda Research Institute for Nutritional Disorders
Outcome results
None listed